# Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy With Nephrotic Syndrome

> clinical trial · VERIFIED · 2026-08-12

Status: ACTIVE_NOT_RECRUITING · Sponsor: Shoichi Maruyama MD PhD · Condition: Glomerulonephritis, Membranous

- Company: Shoichi Maruyama MD PhD
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT05914155

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.